{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:01:18Z","timestamp":1760853678351,"version":"3.40.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s10822-013-9649-3","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T01:08:02Z","timestamp":1367370482000},"page":"337-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of ligands that target the HCV-E2 binding site on CD81"],"prefix":"10.1007","volume":"27","author":[{"given":"Reem Al","family":"Olaby","sequence":"first","affiliation":[]},{"given":"Hassan M.","family":"Azzazy","sequence":"additional","affiliation":[]},{"given":"Rodney","family":"Harris","sequence":"additional","affiliation":[]},{"given":"Brett","family":"Chromy","sequence":"additional","affiliation":[]},{"given":"Jost","family":"Vielmetter","sequence":"additional","affiliation":[]},{"given":"Rod","family":"Balhorn","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,4,24]]},"reference":[{"issue":"Supplement 1","key":"9649_CR1","first-page":"3","volume":"31","author":"C Ferrari","year":"1999","unstructured":"Ferrari C, Urbani S, Penna A, Cavalli A, Valli A, Lamonaca V, Bertoni R, Boni C, Barbieri K, Uggeri J, Fiaccadori F (1999) Immunopathogenesis of hepatitis C virus infection. J Hepat 31(Supplement 1):3\u20138","journal-title":"J Hepat"},{"key":"9649_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1046\/j.1365-2893.1999.00152.x","volume":"6","author":"R Bartenschlager","year":"1999","unstructured":"Bartenschlager R (1999) The NS3\/4A proteinase of the hepatitis C virus: unraveling structure and function of an unusual enzyme and a prime target for antiviral therapy. J Viral Hepat 6:165\u2013181","journal-title":"J Viral Hepat"},{"key":"9649_CR3","first-page":"289","volume":"1","author":"CA Lesburg","year":"2000","unstructured":"Lesburg CA, Radfar R, Weber PC (2000) Recent advances in the analysis of HCV NS5B RNA-dependent RNA polymerase. Curr Opin Investig Drugs 1:289\u2013296","journal-title":"Curr Opin Investig Drugs"},{"key":"9649_CR4","first-page":"63","volume":"9","author":"S Welbourn","year":"2007","unstructured":"Welbourn S, Pause A (2007) The hepatitis C virus NS2\/3 protease. Curr Issues Mol Biol 9:63\u201369","journal-title":"Curr Issues Mol Biol"},{"key":"9649_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1517\/13543770903044994","volume":"19","author":"S Venkatraman","year":"2009","unstructured":"Venkatraman S, Njoroge FG (2009) Macrocyclic inhibitors of HCV NS3 protease. Expert Opin Ther Pat 19:1277\u20131303","journal-title":"Expert Opin Ther Pat"},{"key":"9649_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2174\/157488709789957628","volume":"4","author":"M Enomoto","year":"2009","unstructured":"Enomoto M, Tamori A, Kawada N (2009) Emerging antiviral drugs for hepatitis C virus. Rev Recent Clin Trials 4:179\u2013184","journal-title":"Rev Recent Clin Trials"},{"key":"9649_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/157488710792007293","volume":"5","author":"A Chary","year":"2010","unstructured":"Chary A, Holodniy M (2010) Recent advances in hepatitis C virus treatment: review of HCV protease inhibitor clinical trials. Rev Recent Clin Trials 5:158\u2013173","journal-title":"Rev Recent Clin Trials"},{"key":"9649_CR8","first-page":"17","volume":"131","author":"SD Sharma","year":"2010","unstructured":"Sharma SD (2010) Hepatitis C virus: molecular biology and current therapeutic options. Indian J Med Res 131:17\u201334","journal-title":"Indian J Med Res"},{"key":"9649_CR9","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1586\/14760584.8.3.333","volume":"8","author":"F Stoll-Keller","year":"2009","unstructured":"Stoll-Keller F, Barth H, Fafi-Kremer S, Zeisel MB, Baumert TF (2009) Development of hepatitis C virus vaccines: challenges and progress. Expert Rev Vaccines 8:333\u2013345","journal-title":"Expert Rev Vaccines"},{"key":"9649_CR10","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3748\/wjg.v13.i17.2406","volume":"13","author":"J Dubuisson","year":"2007","unstructured":"Dubuisson J (2007) Hepatitis C virus proteins. World J Gastroenterol 13:2406\u20132415","journal-title":"World J Gastroenterol"},{"key":"9649_CR11","first-page":"93","volume":"58","author":"A Budkowska","year":"2009","unstructured":"Budkowska A (2009) Mechanism of cell infection with hepatitis C virus (HCV)\u2014a new paradigm in virus-cell interaction. Pol J Microbiol 58:93\u201398","journal-title":"Pol J Microbiol"},{"key":"9649_CR12","doi-asserted-by":"publisher","first-page":"41624","DOI":"10.1074\/jbc.M305289200","volume":"278","author":"B Bartosch","year":"2003","unstructured":"Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, Pascale S, Scarselli E, Cortese R, Nicosia A, Cosset FL (2003) Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278:41624\u201341630","journal-title":"J Biol Chem"},{"key":"9649_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virol.2005.12.027","volume":"348","author":"B Bartosch","year":"2006","unstructured":"Bartosch B, Cosset FL (2006) Cell entry of hepatitis C virus. Virology 348:1\u201312","journal-title":"Virology"},{"key":"9649_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1126\/science.282.5390.938","volume":"282","author":"P Pileri","year":"1998","unstructured":"Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S (1998) Binding of hepatitis C virus to CD81. Science 282:938\u2013941","journal-title":"Science"},{"key":"9649_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.immunol.16.1.89","volume":"16","author":"S Levy","year":"1998","unstructured":"Levy S, Todd SC, Maecker HT (1998) CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Ann Rev Immunol 16:89\u2013109","journal-title":"Ann Rev Immunol"},{"key":"9649_CR16","doi-asserted-by":"publisher","first-page":"4824","DOI":"10.1128\/JVI.74.10.4824-4830.2000","volume":"74","author":"R Petracca","year":"2000","unstructured":"Petracca R, Falugi F, Galli G, Norais N, Rosa D, Campagnoli S, Burgio V, Di Stasio E, Giardina B, Houghton M, Abrignani S, Grandi G (2000) Structure-function analysis of hepatitis C virus envelope-CD81 binding. J Virol 74:4824\u20134830","journal-title":"J Virol"},{"key":"9649_CR17","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1128\/JVI.74.8.3642-3649.2000","volume":"74","author":"A Higginbottom","year":"2000","unstructured":"Higginbottom A, Quinn ER, Kuo CC, Flint M, Wilson LH, Bianchi E, Nicosia A, Monk PN, McKeating JA, Levy S (2000) Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol 74:3642\u20133649","journal-title":"J Virol"},{"key":"9649_CR18","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1128\/JVI.02391-09","volume":"84","author":"YY Zhang","year":"2010","unstructured":"Zhang YY, Zhang BH, Ishii K, Liang TJ (2010) Novel function of CD81 in controlling hepatitis C virus replication. J Virol 84:3396\u20133407","journal-title":"J Virol"},{"key":"9649_CR19","doi-asserted-by":"publisher","first-page":"11143","DOI":"10.1128\/JVI.76.21.11143-11147.2002","volume":"76","author":"HE Drummer","year":"2002","unstructured":"Drummer HE, Wilson KA, Poumbourios P (2002) Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81. J Virol 76:11143\u201311147","journal-title":"J Virol"},{"key":"9649_CR20","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0042-6822(03)00406-9","volume":"314","author":"SE VanCompernolle","year":"2003","unstructured":"VanCompernolle SE, Wiznycia AV, Rush JR, Dhanasekaran M, Baures PW, Todd SC (2003) Small molecule inhibition of hepatitis C virus E2 binding to CD81. Virology 314:371\u2013380","journal-title":"Virology"},{"key":"9649_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/emboj\/20.1.12","volume":"20","author":"K Kitadokoro","year":"2001","unstructured":"Kitadokoro K, Bordo D, Galli G, Petracca R, Falugi F, Abrignani S, Grandi G, Bolognesi M (2001) CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs. EMBO J 20:12\u201318","journal-title":"EMBO J"},{"key":"9649_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1107\/S0907444900015468","volume":"57","author":"K Kitadokoro","year":"2001","unstructured":"Kitadokoro K, Galli G, Petracca R, Falugi F, Grandi G, Bolognesi M (2001) Crystallization and preliminary crystallographic studies on the large extracellular domain of human CD81, a tetraspanin receptor for hepatitis C virus. Acta Crystallogr D Biol Crystallogr 57:156\u2013158","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"9649_CR23","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.bmcl.2004.01.036","volume":"14","author":"A Neugebauer","year":"2004","unstructured":"Neugebauer A, Klein CDP, Hartmann RW (2004) Protein-dynamics of the putative HCV receptor CD81 large extracellular loop. Bioorg Med Chem Lett 14:1765\u20131769","journal-title":"Bioorg Med Chem Lett"},{"key":"9649_CR24","doi-asserted-by":"publisher","first-page":"5621s","DOI":"10.1158\/1078-0432.CCR-07-1128","volume":"13","author":"R Balhorn","year":"2007","unstructured":"Balhorn R, Hok S, Burke PA, Lightstone FC, Cosman M, Zemla A, Mirick G, Perkins J, Natarajan A, Corzett M, DeNardo SJ, Albrecht H, Gregg JP, DeNardo GL (2007) Selective high-affinity ligand antibody mimics for cancer diagnosis and therapy: initial application to lymphoma\/leukemia. Clin Cancer Res 13:5621s\u20135628s","journal-title":"Clin Cancer Res"},{"key":"9649_CR25","unstructured":"AutoDock website: http:\/\/autodock.scripps.edu"},{"key":"9649_CR26","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"GM Morris","year":"1998","unstructured":"Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AK (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639\u20131662","journal-title":"J Comput Chem"},{"key":"9649_CR27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/jcc.20634","volume":"28","author":"R Huey","year":"2007","unstructured":"Huey R, Morris GM, Olson AJ, Goodsell DS (2007) A semi empirical free energy force field with charge-based desolvation. J Comput Chem 28:1145\u20131152","journal-title":"J Comput Chem"},{"key":"9649_CR28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2174\/1570180043485581","volume":"1","author":"R Huey","year":"2004","unstructured":"Huey R, Goodsell DS, Morris GM, Olson AJ (2004) Grid-based hydrogen bond potentials with improved directionality. Lett Drug Des Discov 1:178\u2013183","journal-title":"Lett Drug Des Discov"},{"key":"9649_CR29","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/prot.21645","volume":"70","author":"R Harris","year":"2008","unstructured":"Harris R, Olson AJ, Goodsell DS (2008) Automated prediction of ligand binding sites in proteins. Proteins 70:1506\u20131517","journal-title":"Proteins"},{"key":"9649_CR30","doi-asserted-by":"crossref","unstructured":"Morris GM, Huey R, Olson A (2008) Using autodock for ligand-receptor docking. Curr Protoc Bioinforma 8\u201314","DOI":"10.1002\/0471250953.bi0814s24"},{"key":"9649_CR31","unstructured":"NBCR website: https:\/\/www.nbcr.net\/pub\/wiki\/index.php?title=Main_Page"},{"key":"9649_CR32","first-page":"57","volume":"17","author":"MF Sanner","year":"1999","unstructured":"Sanner MF (1999) Python: a programming language for software integration and development. J Mol Graph Model 17:57\u201361","journal-title":"J Mol Graph Model"},{"key":"9649_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/ardp.200700261","volume":"341","author":"M Holzer","year":"2008","unstructured":"Holzer M, Ziegler S, Neugebauer A, Kronenberger B, Klein CD, Hartmann RW (2008) Structural modifications of salicylates: inhibitors of human CD81-receptor HCV-E2 interaction. Arch Pharm (Weinheim) 341:478\u2013484","journal-title":"Arch Pharm (Weinheim)"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9649-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-013-9649-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9649-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-013-9649-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:58:38Z","timestamp":1744149518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-013-9649-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["9649"],"URL":"https:\/\/doi.org\/10.1007\/s10822-013-9649-3","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"type":"print","value":"0920-654X"},{"type":"electronic","value":"1573-4951"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"27 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}